Výsledky vyhledávání - "S S, Mirshahi"

The plasminogen-activation system in ovarian tumors

Autor: S. S. Mirshahi, Claudine Soria, H. R. Lijnen, A. Bernadou, He Lu, P. Burtin, Jeannette Soria, Egbert K. O. Kruithof, E. Pujade-Lauraine

Publikováno v: International Journal of Cancer. 55:27-31

We studied the plasminogen activation system in tumor tissue by measuring the antigen level of the 2 plasminogen activators, tissue-type (t-PA) and urokinase-type (U-PA) and their inhibitors, plasminogen-activator inhibitors type-1 (PAI-1) and type-2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39bdef84b3b242edf3fc38e7e044b22d
https://doi.org/10.1002/ijc.2910550106

Zobrazit plný text záznamu

Incubation of monocytes with adriamycin increases secretion of hepatocyte stimulating factor for fibrinogen biosynthesis

Autor: Jeannette Soria, A. Bernadou, Claudine Soria, M. Mirshahi, Marc Vasse, E. Pujade-Lauraine, J. L. Taupin, S. S. Mirshahi, J. F. Moreau

Publikováno v: Blood Coagulation & Fibrinolysis. 4:149-152

This work provides evidence that the production by monocytes of hepatocyte stimulating factor(s) for fibrinogen biosynthesis was dramatically increased when monocytes were exposed to Adriamycin. This effect was related to an increased production of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b120c1381c033a0635dbb424f504cb96
https://doi.org/10.1097/00001721-199302000-00026

Zobrazit plný text záznamu

Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes

Autor: Jeannette Soria, S. S. Mirshahi, Marc Vasse, Claudine Soria, M. Monconduit, M. Mirshahi, Jeanne-Yvonne Borg

Publikováno v: Blood Coagulation & Fibrinolysis. 4:143-147

As fibrinogen is an independent risk factor for arterial thrombosis we were interested in analysing the mechanism controlling fibrinogen biosynthesis. In this work, we showed that incubation of monocytes with lymphocytes increased hepatocyte stimulat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dfb085cbbe04d512e6ae246e99a64e9f
https://doi.org/10.1097/00001721-199302000-00025

Zobrazit plný text záznamu

D-dimer and CA 125 levels in patients with ovarian cancer during antineoplastic therapy prognostic significance for the success of anti-cancer treatment

Autor: J. Fretault, M. Mirshahi, A. Bernadou, Claudine Soria, Jeannette Soria, E. Pujade-Lauraine, S. S. Mirshahi

Publikováno v: Cancer. 69:2289-2292

In patients with ovarian cancer before they receive chemotherapy, the level of fibrin degradation products (D-dimer), is correlated with the tumor load. In this study, the evolution of D-dimer was compared in patients receiving antineoplastic therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70a1bb616cdff5ba47e53d2e0cdbe7b8
https://doi.org/10.1002/1097-0142(19920501)69:9<2289::aid-cncr2820690914>3.0.co

Zobrazit plný text záznamu

K006 L’aldosterone perturbe l’hemostase en augmentant l’expression par les cellules endotheliales humaines du recepteur de la proteine C

Autor: M. Mirshahi, S.-S. Mirshahi, M.-K. Agarwal, E. Ducros, A.M. Faussat, A. Berthaut, J. Soria

Publikováno v: Archives of Cardiovascular Diseases. 102

Introduction L’activation du systeme renine-angiotensinealdosterone est impliquee dans des dysfonctions vasculaires. La concentration plasmatique d’aldosterone est un facteur de risque de mortalite dans les affections cardiovasculaires. L’aldos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb15c477adce0d2c24427a165071ab2

Zobrazit plný text záznamu

Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)--Val) characterized by a defective fibrin polymerization site 'a'

Autor: K C, Lounes, C, Soria, S S, Mirshahi, P, Desvignes, M, Mirshahi, O, Bertrand, P, Bonnet, J, Koopman, J, Soria

Publikováno v: Blood. 96(10)

Congenital homozygous dysfibrinogenemia was diagnosed in a man with a history of 2 thrombotic strokes before age 30. His hemostatic profile was characterized by a dramatically prolonged plasma thrombin clotting time, and no clotting was observed with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2778e34b83350d431818624a82e21ac2
https://pubmed.ncbi.nlm.nih.gov/11071644

Zobrazit plný text záznamu

Thrombotic dysfibrinogenemia. Fibrinogen 'Caracas V' relation between very tight fibrin network and defective clot degradability

Autor: R, Marchi, S S, Mirshahi, C, Soria, M, Mirshahi, M, Zohar, J P, Collet, N B, de Bosch, C L, Arocha-Piñango, J, Soria

Publikováno v: Thrombosis research. 99(2)

Fibrinogen Caracas V is a thrombotic dysfibrinogenemia with an Aalpha 532 Ser--Cys mutation characterized by a tight fibrin network formed of thin fibers responsible for a less porous clot than a normal one. In the present work, fibrinogen Caracas V

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3b248de8996268aae112f5b107854b60
https://pubmed.ncbi.nlm.nih.gov/10946093

Zobrazit plný text záznamu

Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13

Autor: Jeannette Soria, Marc Vasse, Claudine Soria, S. S. Mirshahi, Vannier Jp, J. Paysant

Publikováno v: British journal of haematology. 93(4)

High levels of fibrinogen are recognized as an important vascular risk factor; however, it is not known if the increase of plasma fibrinogen is directly responsible for this risk, or is only a marker of vascular inflammation. To support this second h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eafbf4162a37240297ffcabe5f7a4b10
https://pubmed.ncbi.nlm.nih.gov/8703833

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání